Emily Mitchell, Executive Director, Decentralised Clinical Trials, contributes to this piece in Clinical Trials Arena on the role of sites in a DCT setting.

© Verdict Media Limited 2023

 

Related information

Webpage

Decentralised & hybrid clinical trials

Whitepaper

Practical considerations in transitioning to hybrid or decentralised clinical trials

Webpage

Agile Clinical Monitoring